The SHAPES pilot project
Interview and article written by Christine Clark With advancing age many people now look forward to a future in which digital solutions will support effective self-management and independent… read more.
Interview and article written by Christine Clark With advancing age many people now look forward to a future in which digital solutions will support effective self-management and independent… read more.
AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 years of age… read more.
Aspirin should be favoured over warfarin to prevent blood clotting in children who undergo a surgery that replumbs their hearts, according to a new study.
Article written by Bruve Sylvester Covid-19 patients treated with preventive blood thinning drugs (prophylactic anticoagulants) within 24 hours of admission to hospital have lower subsequent mortality than covid-19… read more.
The FDA has approved the PD-1 inhibitor Libtayo (cemiplimab-rwlc) from Sanofi as the first immunotherapy indicated for patients with advanced basal cell carcinoma (BCC) previously treated with a… read more.
Article written by Bruce Sylvester Researchers report that ivabradine, a drug used for heart failure, appears to improve symptoms of postural orthostatic tachycardia syndrome, also known as POTS.
Sinovac Biotech has announced phase III results of CoronaVac in COVID-19 treatment.
Article written by Bruce Sylvester Colchicine, a gout treatment, appears to reduce the need for oxygen therapy in COVID-19 patients, researchers reported on Feb. 4, 2021 in the… read more.
Merck announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of an expanded… read more.
Interview and article by Christine Clark. Ivermectin is a good treatment to use interim to and complementary to immunisations, according to Dr David Scheim, one of the authors… read more.
In an analysis, submitted as a pre-print prior to peer-review publication, a two-dose regimen of the ChAdOx1 nCoV-19 vaccine provides minimal protection against mild-moderate COVID-19 infection from the… read more.
Interview and article by Christine Clark. Dr David Scheim, one of the authors of a recent study in Peru, describes the doses of ivermectin that were used and… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.